QPS Netherlands, is a division of QPS Holdings, LLC, a full-service Contract Research Organization (CRO) with extensive experience supporting sponsor's drug development projects from discovery thru post-marketing studies. QPS Netherlands employs over 100 people, and provides a full suite of CRO drug development services, from bioanalysis to clinical research services, to support local and global clinical trials. QPS Netherlands, located near the University Medical Center Groningen (UMCG), has state-of-the-art large and small molecule bioanalytical laboratories, and all the clinical operations support staff and capabilities necessary for the successful planning, execution, and analysis of Phase I – IV clinical trials, ranging from small studies to complex, multinational projects.
| Website | http://www.qps.com |
| Revenue | $235.7 million |
| Employees | 107 (91 on RocketReach) |
| Founded | 1995 |
| Industry | Pharmaceutical Manufacturing, Bioanalysis, Phase II - IV Clinical Services, Early Stage Development |
| Web Rank | 4 Million |
| Keywords | Full Service Cro, Clinical Research Organization, Clinical Trials, Phase I-Iv Trials, Therapeutic Areas, Pharmaceutical Services, Drug Development, Biotechnology, Contract Research, Healthcare, Life Sciences, Medical Research, Clinical Development, Regulatory Affairs, Pharmacovigilance, Data Management, Biostatistics, Medical Devices, Healthcare Consulting |
| Competitors | Thermo Fisher Scientific, SGS, Bureau Veritas Group, Charles River Laboratories, Eurofins, Intertek, TÜV Rheinland Group, Aalborg University, Exova Warringtonfire New Delhi, Virginia Beach Visuals +49 more (view full list) |
Looking for a particular QPS Netherlands B.V. employee's phone or email?
The QPS Netherlands B.V. annual revenue was $235.7 million in 2026.
Daniel Schulz-Jander is the Sr. Director of QPS Netherlands B.V..
91 people are employed at QPS Netherlands B.V..